TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,271 | +4.4% | 2,473,910 | +6.0% | 0.05% | +2.2% |
| Q2 2023 | $36,670 | +110.5% | 2,334,195 | +120.8% | 0.04% | +95.7% |
| Q1 2023 | $17,424 | -71.4% | 1,057,275 | -72.9% | 0.02% | -72.9% |
| Q4 2022 | $60,907 | -99.7% | 3,904,296 | +171.3% | 0.08% | +203.6% |
| Q3 2022 | $18,665,000 | +28.7% | 1,439,118 | +39.3% | 0.03% | +33.3% |
| Q2 2022 | $14,505,000 | +526.3% | 1,033,086 | +538.8% | 0.02% | +600.0% |
| Q1 2022 | $2,316,000 | +56.9% | 161,713 | +84.4% | 0.00% | +50.0% |
| Q2 2021 | $1,476,000 | -69.0% | 87,700 | -66.4% | 0.00% | -66.7% |
| Q1 2021 | $4,768,000 | +13.3% | 261,131 | +13.0% | 0.01% | 0.0% |
| Q4 2020 | $4,207,000 | -47.6% | 231,178 | -48.6% | 0.01% | -53.8% |
| Q3 2020 | $8,023,000 | -16.3% | 449,745 | -15.9% | 0.01% | -27.8% |
| Q2 2020 | $9,585,000 | +52.1% | 534,578 | +28.8% | 0.02% | 0.0% |
| Q1 2020 | $6,300,000 | +627.5% | 415,001 | +845.7% | 0.02% | +800.0% |
| Q4 2019 | $866,000 | -99.0% | 43,883 | -99.0% | 0.00% | -99.0% |
| Q1 2019 | $85,973,000 | +35.5% | 4,220,584 | +11.9% | 0.20% | +22.3% |
| Q4 2018 | $63,449,000 | – | 3,772,245 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |